Cross-Presenting XCR1⁺ Dendritic Cells as Targets for Cancer Immunotherapy

by Katherine M. Audsley, Alison M. McDonnell, Jason Waithman
Published 2020-02-01

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)

by Samantha Barnes, Ophelia Schilizzi, Katherine M. Audsley, Hannah V. Newnes, Bree Foley
Published 2020-11-01

Type I interferon subtypes differentially activate the anti-leukaemic function of natural killer cells

by Samantha A. Barnes, Samantha A. Barnes, Katherine M. Audsley, Katherine M. Audsley, Hannah V. Newnes, Hannah V. Newnes, Sonia Fernandez, Emma de Jong, Jason Waithman, Jason Waithman, Bree Foley
Published 2022-11-01

Directing the Future Breakthroughs in Immunotherapy: The Importance of a Holistic Approach to the Tumour Microenvironment

by Hannah V. Newnes, Jesse D. Armitage, Katherine M. Audsley, Anthony Bosco, Jason Waithman
Published 2021-11-01

Diverse Anti-Tumor Immune Potential Driven by Individual IFNα Subtypes

by Anthony C. Buzzai, Teagan Wagner, Katherine M. Audsley, Hannah V. Newnes, Lucy W. Barrett, Samantha Barnes, Ben C. Wylie, Shane Stone, Alison McDonnell, Alison McDonnell, Vanessa S. Fear, Bree Foley, Jason Waithman
Published 2020-04-01

IFNβ Is a Potent Adjuvant for Cancer Vaccination Strategies

by Katherine M. Audsley, Teagan Wagner, Teagan Wagner, Clara Ta, Hannah V. Newnes, Anthony C. Buzzai, Anthony C. Buzzai, Samantha A. Barnes, Ben Wylie, Jesse Armitage, Tsuneyasu Kaisho, Anthony Bosco, Alison McDonnell, Mark Cruickshank, Vanessa S. Fear, Bree Foley, Jason Waithman
Published 2021-09-01